Anti-A and anti-B titers in pooled group O platelets are comparable to apheresis platelets

Transfusion

Volumn 48, Issue 10, 2008, Pages 2106-2113

  Cooling, Laura L ^a   Downs, Theresa A ^a   Butch, Suzanne H ^a   Davenport, Robertson D ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTININ; THROMBOCYTE CONCENTRATE;

ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; APHERESIS; ARTICLE; BLOOD TRANSFUSION; DILUTION; HUMAN; HUMAN TISSUE; THROMBOCYTE;

ABO BLOOD-GROUP SYSTEM; ACUTE DISEASE; AGGLUTINATION TESTS; ANTIGENS, HUMAN PLATELET; BLOOD COMPONENT REMOVAL; BLOOD GROUP INCOMPATIBILITY; BLOOD PLATELETS; HUMANS; ISOANTIGENS; PLATELET TRANSFUSION; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 52949109713     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01814.x     Document Type: Article

References (37)

1. Cooling L. ABO and platelet transfusion therapy. Immunohematology 2007 23 : 20 33.
2. Fung MK, Downes KA, Shulman IA. Transfusion of platelets containing ABO-incompatible plasma. Arch Pathol Lab Med 2007 131 : 909 16.
3. Harris SB, Josephson CD, Kost CB, Hillyer CD. Nonfatal intravascular hemolysis in a pediatric patient after transfusion of a platelet unit with high-titer anti-A. Transfusion 2007 47 : 1412 7.
4. Schwartz J, Depalma H, Kapoor K, Hamilton T, Grima K. Anti-A titers in group O single donor platelets: to titer or not to titer [abstract Transfusion 2003 43 Suppl : SP247.
5. Fauzie D, Shirey RS, Thoman S, Bensen-Kennedy D, King KE. The risk of hemolytic transfusion reactions due to passively-acquired ABO antibodies: a retrospective study of non-group O adult recipients of group O plateletpheresis transfusions [abstract Transfusion 2004 44 Suppl : SP10.
6. Mair B, Benson K. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets. Transfusion 1998 38 : 51 5.
7. Larsson LG, Welsh VJ, Ladd DJ. Acute intravascular hemolysis secondary to out-of-group platelet transfusion. Transfusion 2000 40 : 902 6.
8. Pietersz RN, Engelfriet CP, Reesink HW. International forum: transfusion of apheresis platelets and ABO groups. Vox Sang 2005 88 : 207 21.
9. Josephson CD, Mullis NC, Van Demark C, Hillyer CD. Significant numbers of apheresis-derived group O platelets have "high titer" anti-A/A,B: implications for transfusion policy. Transfusion 2004 44 : 805 8.
10. Brecher M. Technical manual. 15th ed. Bethesda (MD) : American Association of Blood Banks 2005.
11. Buffered MTS gel card (direction circular). Pompano Beach (FL) : Micro Typing Systems 1994.
12. Friedberg RC, Donnelly SF, Boyd JC, Gray LS, Mintz PD. Clinical and blood bank factors in the management of platelet refractoriness. Blood 1993 81 : 3428 34.
13. Slichter SJ, Davis K, Enright H, Braine H, Gernsheimer T, Kao KJ, Kickler T, Lee E, McFarland J, McCullough J, Rodey G, Schiffer CA, Woodson RW. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005 105 : 4106 14.
14. Cooling LL, Kelly K, Barton J, Hwang D, Koerner TA, Olson JD. Determinants of ABH expression on human blood platelets. Blood 2005 105 : 3356 64.
15. Jimenez TM, Patel SB, Pineda AA, Tefferi A, Owen WG. Factors that influence platelet recovery after transfusion: resolving donor quality from ABO compatibility. Transfusion 2003 43 : 328 34.
16. Heal JM, Blumberg N, Masel D. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients. Blood 1987 70 : 23 30.
17. Brand A, Sintnicolaas K, Claas FH, Eernisse JG. ABH antibodies causing platelet transfusion refractoriness. Transfusion 1986 26 : 463 6.
18. Langston MM, Procter JL, Cipolone KM, Stroncek DF. Evaluation of the gel system for ABO grouping and D typing. Transfusion 1999 39 : 300 5.
19. Kettler DS, Johnson MM. ABO grouping: experience with the gel test [abstract]. Transfusion 1997 37 Suppl : 29S.
20. Mazda T, Yabe R, NaThalang O, Thammavong T, Tadokoro K. Differences in ABO antibody among blood donors: a comparison between past and present Japanese, Laotian, and Thai populations. Immunohematology 2007 23 : 38 41.
21. Saphire DG, Rudolph NS, Hackleman SM, Stone WH. The effect of age on the level of human ABO blood group antibodies. Aging Clin Exp Res 1993 5 : 177 84.
22. Aubert EF, Boorman KE, Dodd BE, Loutit JF. The universal donor with high titre iso-agglutinins: the effect of anti-A iso-agglutinins on recipients of group A. BMJ 1942 1 : 659 64.
23. Tisdall LH, Garland DM, Szanto PB, Hand AM, Bonnett JC. The effects of high isoagglutinin titer into recipients of other blood groups. Am J Clin Pathol 1946 16 : 193 206.
24. Ebert RV, Emerson CP. A clinical study of transfusion reactions: the hemolytic effect of group-O blood and pooled plasma containing incompatible isoagglutinins. J Clin Invest 1946 25 : 627 38.
25. Thalhimer W, Taylor ES. The low agglutinin titer of both small and large pools of plasma. JAMA 1945 128 : 277 9.
26. Beading W, Cooling LW. Immunohematology. In : McPherson RA, Pinkus MR, editors. Henry's clinical diagnosis and management by laboratory methods. 21st ed. Philadelphia (PA) : WB Saunders 2007. p. 619 69.
27. Klendshoj NC, Witebsky E. Transfusion of O blood conditioned by the addition of blood group specific substances. JAMA 1945 129 : 1091 3.
28. Miller EB, Tisdall LH. Reactions to 10,000 pooled liquid human plasma transfusions. JAMA 1945 128 : 863 7.
29. Solheim BG. Universal pathogen-reduced plasma in elective open-heart surgery and liver resection. Clin Med Res 2006 4 : 209 17.
30. Chapanduka ZC, Fernandes-Costa FJ, Rochat C, Blyth DF. Comparative safety and efficacy of Bioplasma FDP versus single-donor fresh-dried plasma in cardiopulmonary bypass patients. S Afr Med J 2002 92 : 356 7.
31. Rochat C, Larkin PM. Determination of proportion of ABO blood groups in manufacture of Bioplasma FDP: a universal plasma? [abstract]. Vox Sang 2006 91 Suppl 3 : P474.
32. Heal JM, Masel D, Blumberg N. Interaction of platelet Fc and complement receptors with circulating immune complexes involving the ABO system. Vox Sang 1996 71 : 205 11.
33. Heal JM, Masel D, Rowe JM, Blumberg N. Circulating immune complexes involving the ABO system after platelet transfusion. Br J Haematol 1993 85 : 566 72.
34. Huang MM, Indik Z, Brass LF, Hoxie JA, Schreiber AD, Brugge JS. Activation of FcγRII induces tyrosine phosphorylation of multiple proteins including FcγRII. J Biol Chem 1992 267 : 5467 73.
35. Sweeney J, Kouttab N, Holme ST, Cheves T, Nelson E. In vitro evaluation of prestorage pools consisting of mixed A and O platelet concentrates. Transfusion 2007 47 : 1154 61.
36. Policies on combining ABO non-identical platelet concentrates in the same pool. CBBS, e-network forum. Sacramento, CA : CBBS Central Office 2004 Aug 22 [cited 2007 Feb 23]. Available from: http://www.cbbsweb.org/enf/2004/ pltpool_mixabo.html.
37. Sadani DT, Urbaniak SJ, Bruce M, Tighes JE. Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction. Transfus Med 2006 16 : 375 9.